Search - tctmd.com

Displaying 961 - 980 of 1088

Sort: Relevancy | Date

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

News Conference News ESC 2017

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

August 27, 2017

Evolocumab Not Cost-Effective at Current List Price

News Daily News

Evolocumab Not Cost-Effective at Current List Price

Michael O'Riordan

August 23, 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On, With Hotly Anticipated Trials

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

August 18, 2017

CMS Reverses Its Course on Bundled Payments for MI, CABG

News Daily News

CMS Reverses Its Course on Bundled Payments for MI, CABG

August 16, 2017

A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease

News Features

A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease

Yael L. Maxwell

August 02, 2017

TCTMD’s Top 10 Most Popular Stories for July 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2017

July 31, 2017

New Absorb BVS Meta-analysis Begs the Question: When to Stop Studying a First-Gen Device?

News Daily News

New Absorb BVS Meta-analysis Begs the Question: When to Stop Studying a First-Gen Device?

July 21, 2017

No Downside to Medicare Penalties for Hospital Readmissions for HF, Acute MI

News Daily News

No Downside to Medicare Penalties for Hospital Readmissions for HF, Acute MI

July 18, 2017

Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See?

News Conference News SCCT 2017

Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See?

Yael L. Maxwell

July 10, 2017

Faster, On-site FFRCT May Be on the Horizon Through Innovation and Collaboration

News Conference News SCCT 2017

Faster, On-site FFRCT May Be on the Horizon Through Innovation and Collaboration

Yael L. Maxwell

July 09, 2017

TCTMD’s Top 10 Most Popular Stories for June 2017

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2017

July 03, 2017

Top-Line REVEAL Results Support Efficacy of CETP Inhibition, but Questions Abound

News Daily News

Top-Line REVEAL Results Support Efficacy of CETP Inhibition, but Questions Abound

June 27, 2017

Smartphone App Mobilizes Members of the Public to Be Cardiac Arrest First Responders

News Daily News

Smartphone App Mobilizes Members of the Public to Be Cardiac Arrest First Responders

June 21, 2017

TCTMD’s Top 10 Most Popular Stories for May 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2017

June 01, 2017

DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit

News Conference News EuroPCR 2017

DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit

Michael O'Riordan

May 16, 2017

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

News Conference News EuroPCR 2017

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

May 12, 2017

Stents as Essential Medicine: India’s Cap on Stent Prices Could Have Ripples Around the Globe

News Features

Stents as Essential Medicine: India’s Cap on Stent Prices Could Have Ripples Around the Globe

May 05, 2017

TCTMD’s Top 10 Most Popular Stories for April 2017

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2017

April 28, 2017

Yet Another Study Underscores Drawbacks of Risk-Adjusted Mortality as a Measure of PCI Quality

News Daily News

Yet Another Study Underscores Drawbacks of Risk-Adjusted Mortality as a Measure of PCI Quality

April 04, 2017

My Takeaways From ACC 2017: Even With a Sea Change, the Tide Takes Its Time

News Conference News ACC 2017

My Takeaways From ACC 2017: Even With a Sea Change, the Tide Takes Its Time

March 23, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.